Increasing diversity in clinical research trials and tackling health inequities will require addressing the mistrust many people feel due to a long history of discrimination in medical research, Kaholokula believes. With a $20 million grant awarded last year by the American Heart Association, Gates Ventures, and Pfizer, Kaholokula will co-lead collaborators from nine universities and health care systems in examining what prevents people underrepresented in research, including Native Hawaiians and Pacific Islanders, from participating in trials, and how to change that. The four-year study will focus on interventions for heart disease, diabetes, and obesity.
Keaweʻaimoku Kaholokula
Chair of Native Hawaiian Health at Burns School of Medicine, University of Hawai‘i at Mānoa
More in Academia
Academia
Alberto Ascherio
Professor of epidemiology and nutrition, Harvard T.H. Chan School of Public Health
Academia
Euan Ashley
Professor of medicine and genomics, Stanford School of Medicine
Academia
Carolyn Bertozzi
Professor of chemistry, Stanford University
Academia
Kirsten Bibbins-Domingo
Editor-in-chief, JAMA
Academia
Maria Elena Bottazzi
Co-director, Texas Children’s Hospital Center for Vaccine Development
Academia
Daniel Dawes
Executive director, Global Health Equity Institute, Meharry Medical College
Academia
Amy Finkelstein
Professor of economics, MIT
Academia
Rachel Hardeman
Director, Center for Antiracism Research for Health Equity, UMN
Academia
Akiko Iwasaki
Professor of immunobiology, Yale School of Medicine
Academia
Jonathan Jackson
Executive director, CARE Research Center at Mass. General
Academia
Marc Lipsitch
Director of science, CDC Center for Forecasting and Outbreak Analytics
Academia
Valerie Montgomery Rice
President & CEO, Morehouse School of Medicine
Academia
Roderic Pettigrew
Dean, Intercollegiate School of Engineering Medicine, Texas A&M
Academia
Anne Rimoin
Professor of Epidemiology, UCLA Fielding School of Public Health
Academia
Emily Wang
Professor, Yale School of Medicine